{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:18:48Z","timestamp":1793013528184,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T00:00:00Z","timestamp":1582502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Competitive Research Funding of the Tampere University Hospital"},{"DOI":"10.13039\/501100007417","name":"Paulo Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scandinavian Rheumatology Research Foundation"},{"name":"Maire Lisko Foundation"},{"name":"Pirkanmaa Regional Fund of the Finnish Cultural Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Retinol binding protein 4 (RBP4) is a member of the lipocalin family and a vitamin A carrier in the blood. More recently, RBP4 has been described as an adipokine that is involved in insulin resistance and metabolic syndrome (MetS). As obesity, MetS and some adipokines contribute to the pathogenesis of osteoarthritis (OA), we investigated RBP4 in patients with OA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Cartilage, synovial fluid and blood samples were collected from 100 OA patients undergoing total knee replacement surgery. Primary chondrocytes and cartilage tissue were cultured to measure the RBP4 expression. The concentrations of RBP4, other adipokines (adipsin, adiponectin, leptin and resistin) and biomarkers of OA (COMP, MMP-1, MMP-3 and YKL-40) were measured by immunoassay, and gene expression was measured by next-generation RNA sequencing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The OA cartilage samples released RBP4 into the culture medium, and the levels correlated positively with the expression of the adipokines adipsin, adiponectin, leptin and resistin. RBP4 was the most prominently expressed of these adipokines in the OA chondrocytes, and the expression of the RBP4 receptors STRA6 (stimulated by retinoic acid gene homologue 6) and TLR4 (Toll-like receptor 4) was also detected. Within the cartilage culture medium, RBP4 showed a positive correlation with MMP-1, MMP-3 and YKL-40. RBP4 was also present in the synovial fluid from the OA patients and correlated positively with the concentrations of RBP4 found in the plasma and the cartilage culture medium. Plasma RBP4 concentrations also showed a positive correlation with MMP-3 and adipsin.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We show here, for the first time, that RBP4 is produced within OA joints and that it is associated with increased levels of adipokines and MMPs. The results suggest a role for RBP4 in the pathogenesis of OA and as a possible target for the disease-modifying drugs for the treatment of OA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00011-020-01326-0","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T08:05:45Z","timestamp":1582531545000},"page":"415-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients"],"prefix":"10.1007","volume":"69","author":[{"given":"Morena","family":"Scotece","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Koskinen-Kolasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Pemmari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Lepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0017-1291","authenticated-orcid":false,"given":"Katriina","family":"Vuolteenaho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,24]]},"reference":[{"issue":"1","key":"1326_CR1","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheumatol. 2008;58(1):26\u201335.","journal-title":"Arthritis Rheumatol"},{"key":"1326_CR2","doi-asserted-by":"publisher","first-page":"16044","DOI":"10.1038\/boneres.2016.44","volume":"5","author":"D Chen","year":"2017","unstructured":"Chen D, Shen J, Zhao W, Wang T, Han L, Hamilton JL, et al. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5:16044.","journal-title":"Bone Res"},{"issue":"6","key":"1326_CR3","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"RF Loeser","year":"2012","unstructured":"Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheumatol. 2012;64(6):1697\u2013707.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1326_CR4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1326_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.drudis.2013.07.012","volume":"19","author":"M Scotece","year":"2014","unstructured":"Scotece M, Conde J, Vuolteenaho K, Koskinen A, L\u00f3pez V, G\u00f3mez-Reino J, et al. Adipokines as drug targets in joint and bone disease. Drug Discov Today. 2014;19(3):241\u201358.","journal-title":"Drug Discov Today"},{"issue":"7049","key":"1326_CR6","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature03711","volume":"436","author":"Q Yang","year":"2005","unstructured":"Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356\u201362.","journal-title":"Nature"},{"issue":"3","key":"1326_CR7","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/S0021-9258(18)46017-6","volume":"267","author":"C Tsutsumi","year":"1992","unstructured":"Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, et al. Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem. 1992;267(3):1805\u201310.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"1326_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0167-4838(00)00150-3","volume":"1482","author":"ME Newcomer","year":"2000","unstructured":"Newcomer ME, Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta. 2000;1482(1\u20132):57\u201364.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"1326_CR9","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1056\/NEJMoa054862","volume":"354","author":"TE Graham","year":"2006","unstructured":"Graham TE, Yang Q, Bl\u00fcher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552\u2013633.","journal-title":"N Engl J Med"},{"issue":"11","key":"1326_CR10","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.2337\/dc06-0360","volume":"29","author":"YM Cho","year":"2006","unstructured":"Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care. 2006;29(11):2457\u201361.","journal-title":"Diabetes Care"},{"issue":"3","key":"1326_CR11","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.metabol.2006.10.011","volume":"56","author":"D-C Lee","year":"2007","unstructured":"Lee D-C, Lee J-W, Im J-A. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism. 2007;56(3):327\u201331.","journal-title":"Metabolism"},{"issue":"2","key":"1326_CR12","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/j.1365-2265.2007.03156.x","volume":"69","author":"J G\u00f3mez-Ambrosi","year":"2008","unstructured":"G\u00f3mez-Ambrosi J, Rodr\u00edguez A, Catal\u00e1n V, Ram\u00edrez B, Silva C, Rotellar F, et al. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass. Clin Endocrinol (Oxf). 2008;69(2):208\u201315.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"1326_CR13","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1210\/jc.2006-2522","volume":"92","author":"M Promintzer","year":"2007","unstructured":"Promintzer M, Krebs M, Todoric J, Luger A, Bischof MG, Nowotny P, et al. Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab. 2007;92(11):4306\u201312.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1326_CR14","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.2337\/dc07-0768","volume":"30","author":"TWK Ng","year":"2007","unstructured":"Ng TWK, Watts GF, Barrett PHR, Rye K-A, Chan DC. Effect of weight loss on LDL and HDL kinetics in the metabolic syndrome: associations with changes in plasma retinol-binding protein-4 and adiponectin levels. Diabetes Care. 2007;30(11):2945\u201350.","journal-title":"Diabetes Care"},{"issue":"12","key":"1326_CR15","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1210\/jc.2007-1219","volume":"92","author":"Q Qi","year":"2007","unstructured":"Qi Q, Yu Z, Ye X, Zhao F, Huang P, Hu FB, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab. 2007;92(12):4827\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1326_CR16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2337\/dc08-1656","volume":"32","author":"E Ingelsson","year":"2009","unstructured":"Ingelsson E, Lind L. Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care. 2009;32(4):733\u20135.","journal-title":"Diabetes Care"},{"issue":"20","key":"1326_CR17","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1128\/MCB.00221-13","volume":"33","author":"M Muenzner","year":"2013","unstructured":"Muenzner M, Tuvia N, Deutschmann C, Witte N, Tolkachov A, Valai A, et al. Retinol-binding protein 4 and its membrane receptor STRA6 control adipogenesis by regulating cellular retinoid homeostasis and retinoic acid receptor \u03b1 activity. Mol Cell Biol. 2013;33(20):4068\u201382.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"1326_CR18","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1096\/fj.201600446R","volume":"30","author":"M Kelly","year":"2016","unstructured":"Kelly M, Widjaja-Adhi MAK, Palczewski G, von Lintig J. Transport of vitamin A across blood-tissue barriers is facilitated by STRA6. FASEB J. 2016;30(8):2985\u201395.","journal-title":"FASEB J"},{"issue":"10","key":"1326_CR19","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1128\/MCB.06193-11","volume":"32","author":"J Norseen","year":"2012","unstructured":"Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, et al. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol Cell Biol. 2012;32(10):2010\u20139.","journal-title":"Mol Cell Biol"},{"issue":"24","key":"1326_CR20","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1128\/MCB.00820-12","volume":"32","author":"KM Farjo","year":"2012","unstructured":"Farjo KM, Farjo RA, Halsey S, Moiseyev G, Ma J-X. Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol Cell Biol. 2012;32(24):5103\u201315.","journal-title":"Mol Cell Biol"},{"issue":"6","key":"1326_CR21","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1210\/en.2015-2022","volume":"157","author":"W Gao","year":"2016","unstructured":"Gao W, Wang H, Zhang L, Cao Y, Bao J-Z, Liu Z-X, et al. Retinol-binding protein 4 induces cardiomyocyte hypertrophy by activating TLR4\/MyD88 pathway. Endocrinology. 2016;157(6):2282\u201393.","journal-title":"Endocrinology"},{"key":"1326_CR22","doi-asserted-by":"crossref","unstructured":"Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheumatol. 1986;29(8):1039\u201349.","DOI":"10.1002\/art.1780290816"},{"key":"1326_CR23","doi-asserted-by":"publisher","first-page":"345838","DOI":"10.1155\/2009\/345838","volume":"2009","author":"K Vuolteenaho","year":"2009","unstructured":"Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, P\u00e4iv\u00e4rinta U, Moilanen T, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage\u2014mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediat Inflamm. 2009;2009:345838.","journal-title":"Mediat Inflamm"},{"issue":"6","key":"1326_CR24","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/ar3512","volume":"13","author":"A Koskinen","year":"2011","unstructured":"Koskinen A, Juslin S, Nieminen R, Moilanen T, Vuolteenaho K, Moilanen E. Adiponectin associates with markers of cartilage degradation in osteoarthritis and induces production of proinflammatory and catabolic factors through mitogen-activated protein kinase pathways. Arthritis Res Ther. 2011;13(6):R184.","journal-title":"Arthritis Res Ther"},{"key":"1326_CR25","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc"},{"issue":"15","key":"1326_CR26","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u2013200.","journal-title":"Bioinformatics"},{"issue":"1","key":"1326_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u2013211.","journal-title":"Bioinformatics"},{"issue":"7","key":"1326_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330.","journal-title":"Bioinformatics"},{"issue":"12","key":"1326_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"key":"1326_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/1471-2164-12-507","volume":"12","author":"MA Kallio","year":"2011","unstructured":"Kallio MA, Tuimala JT, Hupponen T, Klemel\u00e4 P, Gentile M, Scheinin I, et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics. 2011;12:507.","journal-title":"BMC Genomics"},{"issue":"8","key":"1326_CR31","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1210\/jc.2007-0209","volume":"92","author":"W Jia","year":"2007","unstructured":"Jia W, Wu H, Bao Y, Wang C, Lu J, Zhu J, et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab. 2007;92(8):3224\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"1326_CR32","doi-asserted-by":"publisher","first-page":"e52533","DOI":"10.1371\/journal.pone.0052533","volume":"7","author":"J Conde","year":"2012","unstructured":"Conde J, Scotece M, L\u00f3pez V, G\u00f3mez R, Lago F, Pino J, et al. Adiponectin and leptin induce VCAM-1 expression in human and murine chondrocytes. PLoS One. 2012;7(12):e52533.","journal-title":"PLoS One"},{"issue":"3","key":"1326_CR33","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.joca.2014.01.002","volume":"22","author":"P-J Francin","year":"2014","unstructured":"Francin P-J, Abot A, Guillaume C, Moulin D, Bianchi A, Gegout-Pottie P, et al. Association between adiponectin and cartilage degradation in human osteoarthritis. Osteoarthr Cartil. 2014;22(3):519\u201326.","journal-title":"Osteoarthr Cartil"},{"issue":"6","key":"1326_CR34","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jor.23377","volume":"35","author":"M Scotece","year":"2017","unstructured":"Scotece M, P\u00e9rez T, Conde J, Abella V, L\u00f3pez V, Pino J, et al. Adipokines induce pro-inflammatory factors in activated CD4+ T cells from osteoarthritis patient. J Orthop Res. 2017;35(6):1299\u2013303.","journal-title":"J Orthop Res"},{"issue":"3","key":"1326_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/03009742.2013.853096","volume":"43","author":"A Koskinen","year":"2014","unstructured":"Koskinen A, Vuolteenaho K, Moilanen T, Moilanen E. Resistin as a factor in osteoarthritis: synovial fluid resistin concentrations correlate positively with interleukin 6 and matrix metalloproteinases MMP-1 and MMP-3. Scand J Rheumatol. 2014;43(3):249\u201353.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1326_CR36","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1038\/s41598-017-04119-4","volume":"7","author":"AM Philp","year":"2017","unstructured":"Philp AM, Collier RL, Grover LM, Davis ET, Jones SW. Resistin promotes the abnormal Type I collagen phenotype of subchondral bone in obese patients with end stage hip osteoarthritis. Sci Rep. 2017;7(1):4042.","journal-title":"Sci Rep"},{"key":"1326_CR37","doi-asserted-by":"crossref","unstructured":"Koskinen A, Vuolteenaho K, Nieminen R, Moilanen T, Moilanen E. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients. Clin Exp Rheumatol. 2011;29(1):57\u201364.","DOI":"10.1016\/S1063-4584(10)60038-6"},{"issue":"11","key":"1326_CR38","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1136\/annrheumdis-2011-201242","volume":"71","author":"K Vuolteenaho","year":"2012","unstructured":"Vuolteenaho K, Koskinen A, Moilanen T, Moilanen E. Leptin levels are increased and its negative regulators, SOCS-3 and sOb-R are decreased in obese patients with osteoarthritis: a link between obesity and osteoarthritis. Ann Rheum Dis. 2012;71(11):1912\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1326_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bcpt.12160","volume":"114","author":"Katriina Vuolteenaho","year":"2013","unstructured":"Vuolteenaho K, Koskinen A, Moilanen E. Leptin\u2014a link between obesity and osteoarthritis. Applications for prevention and treatment. Basic Clin Pharmacol Toxicol. 2014;114(1):103\u20138.","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"1326_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.lfs.2015.05.025","volume":"140","author":"M Scotece","year":"2015","unstructured":"Scotece M, Mobasheri A. Leptin in osteoarthritis: focus on articular cartilage and chondrocytes. Life Sci. 2015;140:75\u20138.","journal-title":"Life Sci"},{"issue":"4","key":"1326_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/rheumatology\/kev408","volume":"55","author":"J Martel-Pelletier","year":"2016","unstructured":"Martel-Pelletier J, Raynauld J-P, Dorais M, Abram F, Pelletier J-P. The levels of the adipokines adipsin and leptin are associated with knee osteoarthritis progression as assessed by MRI and incidence of total knee replacement in symptomatic osteoarthritis patients: a post hoc analysis. Rheumatology (Oxford). 2016;55(4):680\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"1326_CR42","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/rheumatology\/key181","volume":"57","author":"G Valverde-Franco","year":"2018","unstructured":"Valverde-Franco G, Tardif G, Mineau F, Par\u00e9 F, Lussier B, Fahmi H, et al. High in vivo levels of adipsin lead to increased knee tissue degradation in osteoarthritis: data from humans and animal models. Rheumatology (Oxford). 2018;57(10):1851\u201360.","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"1326_CR43","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1002\/art.11303","volume":"48","author":"H Dumond","year":"2003","unstructured":"Dumond H, Presle N, Terlain B, Mainard D, Loeuille D, Netter P, et al. Evidence for a key role of leptin in osteoarthritis. Arthritis Rheumatol. 2003;48(11):3118\u2013299.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1326_CR44","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2014.01.018","volume":"19","author":"PM Moraes-Vieira","year":"2014","unstructured":"Moraes-Vieira PM, Yore MM, Dwyer PM, Syed I, Aryal P, Kahn BB. RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance. Cell Metab. 2014;19(3):512\u201326.","journal-title":"Cell Metab"},{"issue":"4","key":"1326_CR45","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/CDLI.5.4.430-437.1998","volume":"5","author":"LI Sakkas","year":"1998","unstructured":"Sakkas LI, Scanzello C, Johanson N, Burkholder J, Mitra A, Salgame P, et al. T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol. 1998;5(4):430\u20137.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1326_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3109\/03009748809102960","volume":"76","author":"HE Jasin","year":"1988","unstructured":"Jasin HE. Immune mediated cartilage destruction. Scand J Rheumatol Suppl. 1988;76:111\u20136.","journal-title":"Scand J Rheumatol Suppl"},{"issue":"4","key":"1326_CR47","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1053\/joca.1998.0224","volume":"7","author":"H Nakamura","year":"1999","unstructured":"Nakamura H, Yoshino S, Kato T, Tsuruha J, Nishioka K. T-cell mediated inflammatory pathway in osteoarthritis. Osteoarthr Cartil. 1999;7(4):401\u20132.","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"1326_CR48","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/joca.2001.0509","volume":"10","author":"H Ishii","year":"2002","unstructured":"Ishii H, Tanaka H, Katoh K, Nakamura H, Nagashima M, Yoshino S. Characterization of infiltrating T cells and Th1\/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthr Cartil. 2002;10(4):277\u201381.","journal-title":"Osteoarthr Cartil"},{"issue":"2","key":"1326_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrrheum.2016.209","volume":"13","author":"V Abella","year":"2017","unstructured":"Abella V, Scotece M, Conde J, Pino J, Gonzalez-Gay MA, G\u00f3mez-Reino JJ, et al. Leptin in the interplay of inflammation, metabolism and immune system disorders. Nat Rev Rheumatol. 2017;13(2):100\u20139.","journal-title":"Nat Rev Rheumatol"},{"key":"1326_CR50","first-page":"185","volume":"23","author":"M Du","year":"2017","unstructured":"Du M, Martin A, Hays F, Johnson J, Farjo RA, Farjo KM. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Mol Vis. 2017;23:185\u201397.","journal-title":"Mol Vis"},{"issue":"1","key":"1326_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13048-018-0397-9","volume":"11","author":"Y Wang","year":"2018","unstructured":"Wang Y, Wang Y, Zhang Z. Adipokine RBP4 drives ovarian cancer cell migration. J Ovarian Res. 2018;11(1):29.","journal-title":"J Ovarian Res"},{"issue":"3","key":"1326_CR52","first-page":"2873","volume":"18","author":"H Li","year":"2018","unstructured":"Li H, Cao G, Zhang N, Lou T, Wang Q, Zhang Z, et al. RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K\/AKT signaling pathway. Mol Med Rep. 2018;18(3):2873\u20139.","journal-title":"Mol Med Rep"},{"issue":"5","key":"1326_CR53","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.joca.2010.08.019","volume":"19","author":"VB Kraus","year":"2011","unstructured":"Kraus VB, Burnett B, Coindreau J, Cottrell S, Eyre D, Gendreau M, et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthr Cartil. 2011;19(5):515\u201342.","journal-title":"Osteoarthr Cartil"},{"issue":"10","key":"1326_CR54","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1002\/art.21345","volume":"52","author":"LS Lohmander","year":"2005","unstructured":"Lohmander LS, Brandt KD, Mazzuca SA, Katz BP, Larsson S, Struglics A, et al. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheumatol. 2005;52(10):3160\u20137.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"1326_CR55","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1210\/jc.2007-0468","volume":"92","author":"Isabelle Aeberli","year":"2007","unstructured":"Aeberli I, Biebinger R, Lehmann R, L\u2019allemand D, Spinas GA, Zimmermann MB. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab. 2007;92(11):4359\u201365.","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"issue":"6","key":"1326_CR56","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1210\/jc.2007-2745","volume":"93","author":"T Reinehr","year":"2008","unstructured":"Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab. 2008;93(6):2287\u201393.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2\u20132","key":"1326_CR57","doi-asserted-by":"publisher","first-page":"e345","DOI":"10.3109\/17477166.2010.491228","volume":"6","author":"D Friebe","year":"2011","unstructured":"Friebe D, Neef M, Erbs S, Dittrich K, Kratzsch J, Kovacs P, et al. Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children. Int J Pediatr Obes. 2011;6(2\u20132):e345\u2013e352352.","journal-title":"Int J Pediatr Obes"},{"issue":"4","key":"1326_CR58","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/oby.2007.138","volume":"16","author":"S Gavi","year":"2008","unstructured":"Gavi S, Qurashi S, Stuart LM, Lau R, Melendez MM, Mynarcik DC, et al. Influence of age on the association of retinol-binding protein 4 with metabolic syndrome. Obesity (Silver Spring). 2008;16(4):893\u20135.","journal-title":"Obesity (Silver Spring)"},{"issue":"4","key":"1326_CR59","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/oby.2009.232","volume":"18","author":"S Lim","year":"2010","unstructured":"Lim S, Yoon JW, Choi SH, Park YJ, Lee JJ, Park JH, et al. Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: the Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring). 2010;18(4):826\u201332.","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"1326_CR60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3945\/jn.113.189860","volume":"144","author":"L Sun","year":"2014","unstructured":"Sun L, Qi Q, Zong G, Ye X, Li H, Liu X, et al. Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults. J Nutr. 2014;144(5):722\u20138.","journal-title":"J Nutr"},{"issue":"12","key":"1326_CR61","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/eurjhf\/hfp153","volume":"11","author":"P Bobbert","year":"2009","unstructured":"Bobbert P, Weith\u00e4user A, Andres J, Bobbert T, K\u00fchl U, Schultheiss HP, et al. Increased plasma retinol binding protein 4 levels in patients with inflammatory cardiomyopathy. Eur J Heart Fail. 2009;11(12):1163\u20138.","journal-title":"Eur J Heart Fail"},{"key":"1326_CR62","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1475-2840-11-52","volume":"11","author":"G Huang","year":"2012","unstructured":"Huang G, Wang D, Khan UI, Zeb I, Manson JE, Miller V, et al. Associations between retinol-binding protein 4 and cardiometabolic risk factors and subclinical atherosclerosis in recently postmenopausal women: cross-sectional analyses from the KEEPS study. Cardiovasc Diabetol. 2012;11:52.","journal-title":"Cardiovasc Diabetol"},{"key":"1326_CR63","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12933-014-0121-z","volume":"13","author":"V Lambadiari","year":"2014","unstructured":"Lambadiari V, Kadoglou NPE, Stasinos V, Maratou E, Antoniadis A, Kolokathis F, et al. Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc Diabetol. 2014;13:121.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01326-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-020-01326-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-020-01326-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T13:12:10Z","timestamp":1650201130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-020-01326-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,24]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1326"],"URL":"https:\/\/doi.org\/10.1007\/s00011-020-01326-0","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,24]]},"assertion":[{"value":"10 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethics Committee of Tampere University Hospital and carried out in accordance with the Declaration of Helsinki. The patients gave their written informed consent to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}